BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21821492)

  • 1. SEOM guidelines for the treatment of malignant pleural mesothelioma.
    Lianes P; Remon J; Bover I; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):569-73. PubMed ID: 21821492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural mesothelioma.
    Chen SE; Pace MB
    Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020).
    Nadal E; Bosch-Barrera J; Cedrés S; Coves J; García-Campelo R; Guirado M; López-Castro R; Ortega AL; Vicente D; de Castro-Carpeño J
    Clin Transl Oncol; 2021 May; 23(5):980-987. PubMed ID: 33538989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary treatment of malignant pleural mesothelioma.
    Ceresoli GL; Gridelli C; Santoro A
    Oncologist; 2007 Jul; 12(7):850-63. PubMed ID: 17673616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of malignant pleural mesothelioma-part 2: therapeutic approaches : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
    Hoda MA; Klikovits T; Arns M; Dieckmann K; Zöchbauer-Müller S; Geltner C; Baumgartner B; Errhalt P; Machan B; Pohl W; Hutter J; Eckmayr J; Studnicka M; Flicker M; Cerkl P; Klepetko W
    Wien Klin Wochenschr; 2016 Sep; 128(17-18):618-26. PubMed ID: 27457872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Belcher E; Cane P; Landau D; Steele J; Taylor H; Spicer J
    J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant pleural mesothelioma: diagnosis and treatment].
    Delourme J; Dhalluin X; Cortot AB; Lafitte JJ; Scherpereel A
    Rev Pneumol Clin; 2013 Feb; 69(1):26-35. PubMed ID: 23333048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Concepts in the Treatment of Malignant Pleural Mesothelioma.
    Wald O; Sugarbaker DJ
    Annu Rev Med; 2018 Jan; 69():365-377. PubMed ID: 29029582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
    Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
    Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
    Lindenmann J; Matzi V; Neuboeck N; Anegg U; Maier A; Smolle J; Smolle-Juettner FM
    Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):237-43. PubMed ID: 23171517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
    Lucchi M; Chella A; Melfi F; Dini P; Ambrogi M; Fino L; Fontanini G; Mussi A
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):529-33; discussion 533-4. PubMed ID: 17188885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
    Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in malignant pleural mesothelioma.
    Kaufman AJ; Pass HI
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
    Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
    J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is pleurectomy and decortication superior to palliative care in the treatment of malignant pleural mesothelioma?
    Zahid I; Sharif S; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):812-7. PubMed ID: 21345818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimodality management of malignant pleural mesothelioma.
    Maggi G; Casadio C; Cianci R; Rena O; Ruffini E
    Eur J Cardiothorac Surg; 2001 Mar; 19(3):346-50. PubMed ID: 11251277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
    Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
    Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic options in malignant pleural mesothelioma].
    Serke M; Loddenkemper R
    Pneumologie; 2005 May; 59(5):337-48. PubMed ID: 15902599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
    Opitz I; Scherpereel A; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell DA; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Putora PM; Cardillo G
    Eur J Cardiothorac Surg; 2020 Jul; 58(1):1-24. PubMed ID: 32448904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.